Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

Akums Drugs and Pharmaceuticals Ltd., has announced its consolidated financial results for the quarter ended December 31, 2024, delivering 12% increase in Adjusted EBITDA on year-on-year basis. Key ...

In the news release, ADPH said it is working with the Center for Disease Control's Division of Healthcare Quality Promotion to investigate 11 reports of people experiencing "adverse events" following ...

The Alabama Department of Public Health issued a statement about its current investigation into certain "adverse events" following an injection.